The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A novel plasma circular RNA circ FARSA is a potential biomarker for non‐small cell lung cancer
Open accessAbstract
Emerging evidence indicates that circular RNA s (circ RNA s) are implicated in cancer development. This study aimed to evaluate whether circulating circ RNA s may serve as novel biomarkers for non‐small cell lung cancer (NSCLC). We used RNA sequencing (RNA‐seq) and quantitative real‐time PCR to explore cancer‐related circ RNA s. Bioinformatics and functional analyses were performed to reveal biological effects of circ RNA s on lung cancer cells. A total of 5471 distinct circ RNA s were identified by total RNA‐seq, in which 185 were differentially expressed between cancerous and adjacent normal tissues. A circ RNA derived from exon 5–7 of the FARSA gene, termed circ FARSA, was observed to increase in cancerous tissues (P = 0.016), and was more abundant in patients’ plasma than controls (P < 0.001). Overexpression of circ FARSA in A549 cell line significantly promoted cell migration and invasion. In silico analysis suggested that circ FARSA might sponge miR‐330‐5p and miR‐326, thereby relieving their inhibitory effects on oncogene fatty acid synthase. Summarily, this study revealed circ RNA profile of NSCLC for the first time and provided the evidence of plasma circ FARSA as a potential noninvasive biomarker for this malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
Complementary Sequence-Mediated Exon Circularization
Zhang, X.-O., Wang, H.-B., Zhang, Y., Lu, X., Chen, L.-L., & Yang, L. (2014) · Cell · doi:10.1016/j.cell.2014.09.001 · Cited by 1,999
Memczak, S., Papavasileiou, P., Peters, O., & Rajewsky, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141214 · Cited by 639
Cited by
Circular RNAs: Promising Biomarkers for Human Diseases
Zhang, Z., Yang, T., & Xiao, J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.07.036 · Cited by 775
RNA sequencing: new technologies and applications in cancer research
Hong, M., Tao, S., Zhang, L., Diao, L.-T., Huang, X., Huang, S., Xie, S.-J., Xiao, Z.-D., & Zhang, H. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01005-x · Cited by 596
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
Li, W., Liu, J.-B., Hou, L.-K., Yu, F., Zhang, J., Wu, W., Tang, X.-M., Sun, F., Lu, H.-M., Deng, J., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01505-z · Cited by 457
CircRNAs in cancer metabolism: a review
Yu, T., Wang, Y., Fan, Y., Fang, N., Wang, T., Xu, T., & Shu, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0776-8 · Cited by 430
CircRNAs and cancer: Biomarkers and master regulators
Arnaiz, E., Sole, C., Manterola, L., Iparraguirre, L., Otaegui, D., & Lawrie, C. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.12.002 · Cited by 415
Metadata
- Authors
- Hang, D., Zhou, J., Qin, N., Zhou, W., Ma, H., Jin, G., Hu, Z., Dai, J., & Shen, H.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2018-05-02
- Volume
- 7
- Issue
- 6
- Pages
- 2783-2791
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2801371079
- Cited by
- 215
- References
- 6
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel plasma circular RNA circ FARSA is a potential biomarker for non‐small cell lung cancer. https://app.cochat.ai/papers/10.1002/cam4.1514
- The paper
- Hang, D., Zhou, J., Qin, N., Zhou, W., Ma, H., Jin, G., Hu, Z., Dai, J., & Shen, H. (2018). A novel plasma circular RNA circ FARSA is a potential biomarker for non‐small cell lung cancer. Cancer Medicine. https://doi.org/10.1002/cam4.1514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.